{"organizations": [], "uuid": "3676021e59996f9ceecda687d0695ab6a40099a2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-labcorp-reports-q4-earnings-per-sh/brief-labcorp-reports-q4-earnings-per-share-6-81-idUSASB0C45N", "country": "US", "domain_rank": 408, "title": "BRIEF-LabCorp Reports Q4 Earnings Per Share $6.81", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-06T14:39:00.000+02:00", "replies_count": 0, "uuid": "3676021e59996f9ceecda687d0695ab6a40099a2"}, "author": "", "url": "https://www.reuters.com/article/brief-labcorp-reports-q4-earnings-per-sh/brief-labcorp-reports-q4-earnings-per-share-6-81-idUSASB0C45N", "ord_in_thread": 0, "title": "BRIEF-LabCorp Reports Q4 Earnings Per Share $6.81", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "labcorp", "sentiment": "none"}, {"name": "reuters) - laboratory corporation of america holdings", "sentiment": "none"}, {"name": "covance", "sentiment": "none"}, {"name": "thomson", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 39 PM / Updated 12 minutes ago BRIEF-LabCorp Reports Q4 Earnings Per Share $6.81 Reuters Staff \nFeb 6 (Reuters) - Laboratory Corporation Of America Holdings : \n* LABCORP ANNOUNCES RECORD 2017 FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2018 GUIDANCE * Q4 EARNINGS PER SHARE $6.81 * Q4 REVENUE ROSE 13.2 PERCENT TO $2.7 BILLION \n* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $11.30 TO $11.70 * Q4 ADJUSTED EARNINGS PER SHARE $2.45 \n* LABCORP SEES 2018 FREE CASH FLOW OF $1.1 BILLION TO $1.2 BILLION \n* Q4 EARNINGS PER SHARE VIEW $2.38, REVENUE VIEW $2.69 BILLION -- THOMSON REUTERS I/B/E/S \n* BACKLOG FOR COVANCE DRUG DEVELOPMENT AT END OF QUARTER WAS $7.13 BILLION \n* LABCORP SEES 2018 REVENUE GROWTH OF 9.5% TO 11.5% OVER 2017 RESTATED REVENUE OF $10.42 BILLION \n* ‍DURING QUARTER, RECORDED A NET BENEFIT OF $519.0 MILLION IN NET EARNINGS, OR $5.00 PER SHARE, DUE TO IMPLEMENTATION OF TAX LAW​ \n* EXPECTS ABOUT $2.8 BILLION OF BACKLOG IN COVANCE DRUG DEVELOPMENT TO CONVERT INTO REVENUE IN NEXT TWELVE MONTHS \n* FY2018 EARNINGS PER SHARE VIEW $10.79, REVENUE VIEW $11.03 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-06T14:39:00.000+02:00", "crawled": "2018-02-06T14:55:59.007+02:00", "highlightTitle": ""}